Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Poxel wraps up enrollment in DESTINY-1 phase 2 trial for PXL065 in NASH Poxel, a French biopharma company, has wrapped up patient enrollment for the phase 2 DESTINY-1 clinical trial, which… bySrinathOctober 9, 2021